Global CDMO for Transdermal Patches and Oral Film Supply, Demand and Key Producers, 2024-2030
The global CDMO for Transdermal Patches and Oral Film market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The market trend for Contract Development and Manufacturing Organizations (CDMO) in the transdermal patches and oral film industry is showing significant growth, with major sales regions including North America, Europe, and Asia Pacific. The market concentration is high, with a few key players dominating the industry and offering a wide range of services such as formulation development, analytical testing, and regulatory support. There are ample market opportunities for CDMOs in this sector, as the demand for innovative drug delivery systems continues to rise, driven by factors such as the increasing prevalence of chronic diseases and the need for convenient and patient-friendly dosage forms. However, there are also challenges to be aware of, such as regulatory hurdles, pricing pressures, and the need for continuous innovation to stay competitive in the market. Overall, the outlook for CDMOs in the transdermal patches and oral film market is positive, with strong growth potential and opportunities for expansion in both established and emerging markets.
CDMO stands for Contract Development and Manufacturing Organization. In the context of transdermal patches and oral films, a CDMO specializing in these dosage forms would offer services such as formulation development, process optimization, scale-up, manufacturing, packaging, and regulatory support for pharmaceutical companies looking to outsource these aspects of their product development. These CDMOs have expertise in developing and manufacturing transdermal patches and oral films, ensuring that they meet quality standards and regulatory requirements.
This report studies the global CDMO for Transdermal Patches and Oral Film demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CDMO for Transdermal Patches and Oral Film, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CDMO for Transdermal Patches and Oral Film that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CDMO for Transdermal Patches and Oral Film total market, 2019-2030, (USD Million)
Global CDMO for Transdermal Patches and Oral Film total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CDMO for Transdermal Patches and Oral Film total market, key domestic companies and share, (USD Million)
Global CDMO for Transdermal Patches and Oral Film revenue by player and market share 2019-2024, (USD Million)
Global CDMO for Transdermal Patches and Oral Film total market by Type, CAGR, 2019-2030, (USD Million)
Global CDMO for Transdermal Patches and Oral Film total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global CDMO for Transdermal Patches and Oral Film market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AdhexPharma, Nissha, Tapemark, tesa, LTS Lohmann, IntelGenx, MedPharm, Adhesives Research and Shilpa Medicare Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CDMO for Transdermal Patches and Oral Film market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global CDMO for Transdermal Patches and Oral Film Market, By Region:
1. How big is the global CDMO for Transdermal Patches and Oral Film market?
2. What is the demand of the global CDMO for Transdermal Patches and Oral Film market?
3. What is the year over year growth of the global CDMO for Transdermal Patches and Oral Film market?
4. What is the total value of the global CDMO for Transdermal Patches and Oral Film market?
5. Who are the major players in the global CDMO for Transdermal Patches and Oral Film market?
The market trend for Contract Development and Manufacturing Organizations (CDMO) in the transdermal patches and oral film industry is showing significant growth, with major sales regions including North America, Europe, and Asia Pacific. The market concentration is high, with a few key players dominating the industry and offering a wide range of services such as formulation development, analytical testing, and regulatory support. There are ample market opportunities for CDMOs in this sector, as the demand for innovative drug delivery systems continues to rise, driven by factors such as the increasing prevalence of chronic diseases and the need for convenient and patient-friendly dosage forms. However, there are also challenges to be aware of, such as regulatory hurdles, pricing pressures, and the need for continuous innovation to stay competitive in the market. Overall, the outlook for CDMOs in the transdermal patches and oral film market is positive, with strong growth potential and opportunities for expansion in both established and emerging markets.
CDMO stands for Contract Development and Manufacturing Organization. In the context of transdermal patches and oral films, a CDMO specializing in these dosage forms would offer services such as formulation development, process optimization, scale-up, manufacturing, packaging, and regulatory support for pharmaceutical companies looking to outsource these aspects of their product development. These CDMOs have expertise in developing and manufacturing transdermal patches and oral films, ensuring that they meet quality standards and regulatory requirements.
This report studies the global CDMO for Transdermal Patches and Oral Film demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for CDMO for Transdermal Patches and Oral Film, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of CDMO for Transdermal Patches and Oral Film that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global CDMO for Transdermal Patches and Oral Film total market, 2019-2030, (USD Million)
Global CDMO for Transdermal Patches and Oral Film total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: CDMO for Transdermal Patches and Oral Film total market, key domestic companies and share, (USD Million)
Global CDMO for Transdermal Patches and Oral Film revenue by player and market share 2019-2024, (USD Million)
Global CDMO for Transdermal Patches and Oral Film total market by Type, CAGR, 2019-2030, (USD Million)
Global CDMO for Transdermal Patches and Oral Film total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global CDMO for Transdermal Patches and Oral Film market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AdhexPharma, Nissha, Tapemark, tesa, LTS Lohmann, IntelGenx, MedPharm, Adhesives Research and Shilpa Medicare Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CDMO for Transdermal Patches and Oral Film market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global CDMO for Transdermal Patches and Oral Film Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Transdermal Patches
- Oral Film
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
- AdhexPharma
- Nissha
- Tapemark
- tesa
- LTS Lohmann
- IntelGenx
- MedPharm
- Adhesives Research
- Shilpa Medicare Limited
- ROFARMA
- Kindeva Drug Delivery
- ProSolus
- Altergon
- Youwei Biotech
1. How big is the global CDMO for Transdermal Patches and Oral Film market?
2. What is the demand of the global CDMO for Transdermal Patches and Oral Film market?
3. What is the year over year growth of the global CDMO for Transdermal Patches and Oral Film market?
4. What is the total value of the global CDMO for Transdermal Patches and Oral Film market?
5. Who are the major players in the global CDMO for Transdermal Patches and Oral Film market?
1 SUPPLY SUMMARY
1.1 CDMO for Transdermal Patches and Oral Film Introduction
1.2 World CDMO for Transdermal Patches and Oral Film Market Size & Forecast (2019 & 2023 & 2030)
1.3 World CDMO for Transdermal Patches and Oral Film Total Market by Region (by Headquarter Location)
1.3.1 World CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.3 China CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.4 Europe CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.5 Japan CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.6 South Korea CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.7 ASEAN CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.8 India CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 CDMO for Transdermal Patches and Oral Film Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CDMO for Transdermal Patches and Oral Film Major Market Trends
2 DEMAND SUMMARY
2.1 World CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.2 World CDMO for Transdermal Patches and Oral Film Consumption Value by Region
2.2.1 World CDMO for Transdermal Patches and Oral Film Consumption Value by Region (2019-2024)
2.2.2 World CDMO for Transdermal Patches and Oral Film Consumption Value Forecast by Region (2025-2030)
2.3 United States CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.4 China CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.5 Europe CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.6 Japan CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.7 South Korea CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.8 ASEAN CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.9 India CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
3 WORLD CDMO FOR TRANSDERMAL PATCHES AND ORAL FILM COMPANIES COMPETITIVE ANALYSIS
3.1 World CDMO for Transdermal Patches and Oral Film Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CDMO for Transdermal Patches and Oral Film Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CDMO for Transdermal Patches and Oral Film in 2023
3.2.3 Global Concentration Ratios (CR8) for CDMO for Transdermal Patches and Oral Film in 2023
3.3 CDMO for Transdermal Patches and Oral Film Company Evaluation Quadrant
3.4 CDMO for Transdermal Patches and Oral Film Market: Overall Company Footprint Analysis
3.4.1 CDMO for Transdermal Patches and Oral Film Market: Region Footprint
3.4.2 CDMO for Transdermal Patches and Oral Film Market: Company Product Type Footprint
3.4.3 CDMO for Transdermal Patches and Oral Film Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CDMO for Transdermal Patches and Oral Film Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CDMO for Transdermal Patches and Oral Film Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: CDMO for Transdermal Patches and Oral Film Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: CDMO for Transdermal Patches and Oral Film Consumption Value Comparison
4.2.1 United States VS China: CDMO for Transdermal Patches and Oral Film Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: CDMO for Transdermal Patches and Oral Film Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based CDMO for Transdermal Patches and Oral Film Companies and Market Share, 2019-2024
4.3.1 United States Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024)
4.4 China Based Companies CDMO for Transdermal Patches and Oral Film Revenue and Market Share, 2019-2024
4.4.1 China Based CDMO for Transdermal Patches and Oral Film Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024)
4.5 Rest of World Based CDMO for Transdermal Patches and Oral Film Companies and Market Share, 2019-2024
4.5.1 Rest of World Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World CDMO for Transdermal Patches and Oral Film Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Transdermal Patches
5.2.2 Oral Film
5.3 Market Segment by Type
5.3.1 World CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024)
5.3.2 World CDMO for Transdermal Patches and Oral Film Market Size by Type (2025-2030)
5.3.3 World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CDMO for Transdermal Patches and Oral Film Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Generic Company
6.3 Market Segment by Application
6.3.1 World CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024)
6.3.2 World CDMO for Transdermal Patches and Oral Film Market Size by Application (2025-2030)
6.3.3 World CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 AdhexPharma
7.1.1 AdhexPharma Details
7.1.2 AdhexPharma Major Business
7.1.3 AdhexPharma CDMO for Transdermal Patches and Oral Film Product and Services
7.1.4 AdhexPharma CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 AdhexPharma Recent Developments/Updates
7.1.6 AdhexPharma Competitive Strengths & Weaknesses
7.2 Nissha
7.2.1 Nissha Details
7.2.2 Nissha Major Business
7.2.3 Nissha CDMO for Transdermal Patches and Oral Film Product and Services
7.2.4 Nissha CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Nissha Recent Developments/Updates
7.2.6 Nissha Competitive Strengths & Weaknesses
7.3 Tapemark
7.3.1 Tapemark Details
7.3.2 Tapemark Major Business
7.3.3 Tapemark CDMO for Transdermal Patches and Oral Film Product and Services
7.3.4 Tapemark CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Tapemark Recent Developments/Updates
7.3.6 Tapemark Competitive Strengths & Weaknesses
7.4 tesa
7.4.1 tesa Details
7.4.2 tesa Major Business
7.4.3 tesa CDMO for Transdermal Patches and Oral Film Product and Services
7.4.4 tesa CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 tesa Recent Developments/Updates
7.4.6 tesa Competitive Strengths & Weaknesses
7.5 LTS Lohmann
7.5.1 LTS Lohmann Details
7.5.2 LTS Lohmann Major Business
7.5.3 LTS Lohmann CDMO for Transdermal Patches and Oral Film Product and Services
7.5.4 LTS Lohmann CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 LTS Lohmann Recent Developments/Updates
7.5.6 LTS Lohmann Competitive Strengths & Weaknesses
7.6 IntelGenx
7.6.1 IntelGenx Details
7.6.2 IntelGenx Major Business
7.6.3 IntelGenx CDMO for Transdermal Patches and Oral Film Product and Services
7.6.4 IntelGenx CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 IntelGenx Recent Developments/Updates
7.6.6 IntelGenx Competitive Strengths & Weaknesses
7.7 MedPharm
7.7.1 MedPharm Details
7.7.2 MedPharm Major Business
7.7.3 MedPharm CDMO for Transdermal Patches and Oral Film Product and Services
7.7.4 MedPharm CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 MedPharm Recent Developments/Updates
7.7.6 MedPharm Competitive Strengths & Weaknesses
7.8 Adhesives Research
7.8.1 Adhesives Research Details
7.8.2 Adhesives Research Major Business
7.8.3 Adhesives Research CDMO for Transdermal Patches and Oral Film Product and Services
7.8.4 Adhesives Research CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Adhesives Research Recent Developments/Updates
7.8.6 Adhesives Research Competitive Strengths & Weaknesses
7.9 Shilpa Medicare Limited
7.9.1 Shilpa Medicare Limited Details
7.9.2 Shilpa Medicare Limited Major Business
7.9.3 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product and Services
7.9.4 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Shilpa Medicare Limited Recent Developments/Updates
7.9.6 Shilpa Medicare Limited Competitive Strengths & Weaknesses
7.10 ROFARMA
7.10.1 ROFARMA Details
7.10.2 ROFARMA Major Business
7.10.3 ROFARMA CDMO for Transdermal Patches and Oral Film Product and Services
7.10.4 ROFARMA CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 ROFARMA Recent Developments/Updates
7.10.6 ROFARMA Competitive Strengths & Weaknesses
7.11 Kindeva Drug Delivery
7.11.1 Kindeva Drug Delivery Details
7.11.2 Kindeva Drug Delivery Major Business
7.11.3 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product and Services
7.11.4 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Kindeva Drug Delivery Recent Developments/Updates
7.11.6 Kindeva Drug Delivery Competitive Strengths & Weaknesses
7.12 ProSolus
7.12.1 ProSolus Details
7.12.2 ProSolus Major Business
7.12.3 ProSolus CDMO for Transdermal Patches and Oral Film Product and Services
7.12.4 ProSolus CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 ProSolus Recent Developments/Updates
7.12.6 ProSolus Competitive Strengths & Weaknesses
7.13 Altergon
7.13.1 Altergon Details
7.13.2 Altergon Major Business
7.13.3 Altergon CDMO for Transdermal Patches and Oral Film Product and Services
7.13.4 Altergon CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Altergon Recent Developments/Updates
7.13.6 Altergon Competitive Strengths & Weaknesses
7.14 Youwei Biotech
7.14.1 Youwei Biotech Details
7.14.2 Youwei Biotech Major Business
7.14.3 Youwei Biotech CDMO for Transdermal Patches and Oral Film Product and Services
7.14.4 Youwei Biotech CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Youwei Biotech Recent Developments/Updates
7.14.6 Youwei Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CDMO for Transdermal Patches and Oral Film Industry Chain
8.2 CDMO for Transdermal Patches and Oral Film Upstream Analysis
8.3 CDMO for Transdermal Patches and Oral Film Midstream Analysis
8.4 CDMO for Transdermal Patches and Oral Film Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 CDMO for Transdermal Patches and Oral Film Introduction
1.2 World CDMO for Transdermal Patches and Oral Film Market Size & Forecast (2019 & 2023 & 2030)
1.3 World CDMO for Transdermal Patches and Oral Film Total Market by Region (by Headquarter Location)
1.3.1 World CDMO for Transdermal Patches and Oral Film Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.3 China CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.4 Europe CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.5 Japan CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.6 South Korea CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.7 ASEAN CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.3.8 India CDMO for Transdermal Patches and Oral Film Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 CDMO for Transdermal Patches and Oral Film Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 CDMO for Transdermal Patches and Oral Film Major Market Trends
2 DEMAND SUMMARY
2.1 World CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.2 World CDMO for Transdermal Patches and Oral Film Consumption Value by Region
2.2.1 World CDMO for Transdermal Patches and Oral Film Consumption Value by Region (2019-2024)
2.2.2 World CDMO for Transdermal Patches and Oral Film Consumption Value Forecast by Region (2025-2030)
2.3 United States CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.4 China CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.5 Europe CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.6 Japan CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.7 South Korea CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.8 ASEAN CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
2.9 India CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030)
3 WORLD CDMO FOR TRANSDERMAL PATCHES AND ORAL FILM COMPANIES COMPETITIVE ANALYSIS
3.1 World CDMO for Transdermal Patches and Oral Film Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global CDMO for Transdermal Patches and Oral Film Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for CDMO for Transdermal Patches and Oral Film in 2023
3.2.3 Global Concentration Ratios (CR8) for CDMO for Transdermal Patches and Oral Film in 2023
3.3 CDMO for Transdermal Patches and Oral Film Company Evaluation Quadrant
3.4 CDMO for Transdermal Patches and Oral Film Market: Overall Company Footprint Analysis
3.4.1 CDMO for Transdermal Patches and Oral Film Market: Region Footprint
3.4.2 CDMO for Transdermal Patches and Oral Film Market: Company Product Type Footprint
3.4.3 CDMO for Transdermal Patches and Oral Film Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: CDMO for Transdermal Patches and Oral Film Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: CDMO for Transdermal Patches and Oral Film Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: CDMO for Transdermal Patches and Oral Film Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: CDMO for Transdermal Patches and Oral Film Consumption Value Comparison
4.2.1 United States VS China: CDMO for Transdermal Patches and Oral Film Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: CDMO for Transdermal Patches and Oral Film Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based CDMO for Transdermal Patches and Oral Film Companies and Market Share, 2019-2024
4.3.1 United States Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
4.3.2 United States Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024)
4.4 China Based Companies CDMO for Transdermal Patches and Oral Film Revenue and Market Share, 2019-2024
4.4.1 China Based CDMO for Transdermal Patches and Oral Film Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024)
4.5 Rest of World Based CDMO for Transdermal Patches and Oral Film Companies and Market Share, 2019-2024
4.5.1 Rest of World Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World CDMO for Transdermal Patches and Oral Film Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Transdermal Patches
5.2.2 Oral Film
5.3 Market Segment by Type
5.3.1 World CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024)
5.3.2 World CDMO for Transdermal Patches and Oral Film Market Size by Type (2025-2030)
5.3.3 World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World CDMO for Transdermal Patches and Oral Film Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotechnology Company
6.2.3 Generic Company
6.3 Market Segment by Application
6.3.1 World CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024)
6.3.2 World CDMO for Transdermal Patches and Oral Film Market Size by Application (2025-2030)
6.3.3 World CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 AdhexPharma
7.1.1 AdhexPharma Details
7.1.2 AdhexPharma Major Business
7.1.3 AdhexPharma CDMO for Transdermal Patches and Oral Film Product and Services
7.1.4 AdhexPharma CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 AdhexPharma Recent Developments/Updates
7.1.6 AdhexPharma Competitive Strengths & Weaknesses
7.2 Nissha
7.2.1 Nissha Details
7.2.2 Nissha Major Business
7.2.3 Nissha CDMO for Transdermal Patches and Oral Film Product and Services
7.2.4 Nissha CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Nissha Recent Developments/Updates
7.2.6 Nissha Competitive Strengths & Weaknesses
7.3 Tapemark
7.3.1 Tapemark Details
7.3.2 Tapemark Major Business
7.3.3 Tapemark CDMO for Transdermal Patches and Oral Film Product and Services
7.3.4 Tapemark CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 Tapemark Recent Developments/Updates
7.3.6 Tapemark Competitive Strengths & Weaknesses
7.4 tesa
7.4.1 tesa Details
7.4.2 tesa Major Business
7.4.3 tesa CDMO for Transdermal Patches and Oral Film Product and Services
7.4.4 tesa CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 tesa Recent Developments/Updates
7.4.6 tesa Competitive Strengths & Weaknesses
7.5 LTS Lohmann
7.5.1 LTS Lohmann Details
7.5.2 LTS Lohmann Major Business
7.5.3 LTS Lohmann CDMO for Transdermal Patches and Oral Film Product and Services
7.5.4 LTS Lohmann CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 LTS Lohmann Recent Developments/Updates
7.5.6 LTS Lohmann Competitive Strengths & Weaknesses
7.6 IntelGenx
7.6.1 IntelGenx Details
7.6.2 IntelGenx Major Business
7.6.3 IntelGenx CDMO for Transdermal Patches and Oral Film Product and Services
7.6.4 IntelGenx CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 IntelGenx Recent Developments/Updates
7.6.6 IntelGenx Competitive Strengths & Weaknesses
7.7 MedPharm
7.7.1 MedPharm Details
7.7.2 MedPharm Major Business
7.7.3 MedPharm CDMO for Transdermal Patches and Oral Film Product and Services
7.7.4 MedPharm CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 MedPharm Recent Developments/Updates
7.7.6 MedPharm Competitive Strengths & Weaknesses
7.8 Adhesives Research
7.8.1 Adhesives Research Details
7.8.2 Adhesives Research Major Business
7.8.3 Adhesives Research CDMO for Transdermal Patches and Oral Film Product and Services
7.8.4 Adhesives Research CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Adhesives Research Recent Developments/Updates
7.8.6 Adhesives Research Competitive Strengths & Weaknesses
7.9 Shilpa Medicare Limited
7.9.1 Shilpa Medicare Limited Details
7.9.2 Shilpa Medicare Limited Major Business
7.9.3 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product and Services
7.9.4 Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Shilpa Medicare Limited Recent Developments/Updates
7.9.6 Shilpa Medicare Limited Competitive Strengths & Weaknesses
7.10 ROFARMA
7.10.1 ROFARMA Details
7.10.2 ROFARMA Major Business
7.10.3 ROFARMA CDMO for Transdermal Patches and Oral Film Product and Services
7.10.4 ROFARMA CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 ROFARMA Recent Developments/Updates
7.10.6 ROFARMA Competitive Strengths & Weaknesses
7.11 Kindeva Drug Delivery
7.11.1 Kindeva Drug Delivery Details
7.11.2 Kindeva Drug Delivery Major Business
7.11.3 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product and Services
7.11.4 Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Kindeva Drug Delivery Recent Developments/Updates
7.11.6 Kindeva Drug Delivery Competitive Strengths & Weaknesses
7.12 ProSolus
7.12.1 ProSolus Details
7.12.2 ProSolus Major Business
7.12.3 ProSolus CDMO for Transdermal Patches and Oral Film Product and Services
7.12.4 ProSolus CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 ProSolus Recent Developments/Updates
7.12.6 ProSolus Competitive Strengths & Weaknesses
7.13 Altergon
7.13.1 Altergon Details
7.13.2 Altergon Major Business
7.13.3 Altergon CDMO for Transdermal Patches and Oral Film Product and Services
7.13.4 Altergon CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Altergon Recent Developments/Updates
7.13.6 Altergon Competitive Strengths & Weaknesses
7.14 Youwei Biotech
7.14.1 Youwei Biotech Details
7.14.2 Youwei Biotech Major Business
7.14.3 Youwei Biotech CDMO for Transdermal Patches and Oral Film Product and Services
7.14.4 Youwei Biotech CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 Youwei Biotech Recent Developments/Updates
7.14.6 Youwei Biotech Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 CDMO for Transdermal Patches and Oral Film Industry Chain
8.2 CDMO for Transdermal Patches and Oral Film Upstream Analysis
8.3 CDMO for Transdermal Patches and Oral Film Midstream Analysis
8.4 CDMO for Transdermal Patches and Oral Film Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World CDMO for Transdermal Patches and Oral Film Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World CDMO for Transdermal Patches and Oral Film Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World CDMO for Transdermal Patches and Oral Film Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CDMO for Transdermal Patches and Oral Film Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World CDMO for Transdermal Patches and Oral Film Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World CDMO for Transdermal Patches and Oral Film Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World CDMO for Transdermal Patches and Oral Film Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key CDMO for Transdermal Patches and Oral Film Players in 2023
Table 12. World CDMO for Transdermal Patches and Oral Film Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global CDMO for Transdermal Patches and Oral Film Company Evaluation Quadrant
Table 14. Head Office of Key CDMO for Transdermal Patches and Oral Film Player
Table 15. CDMO for Transdermal Patches and Oral Film Market: Company Product Type Footprint
Table 16. CDMO for Transdermal Patches and Oral Film Market: Company Product Application Footprint
Table 17. CDMO for Transdermal Patches and Oral Film Mergers & Acquisitions Activity
Table 18. United States VS China CDMO for Transdermal Patches and Oral Film Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China CDMO for Transdermal Patches and Oral Film Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
Table 21. United States Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies CDMO for Transdermal Patches and Oral Film Revenue Market Share (2019-2024)
Table 23. China Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (Province, Country)
Table 24. China Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies CDMO for Transdermal Patches and Oral Film Revenue Market Share (2019-2024)
Table 26. Rest of World Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies CDMO for Transdermal Patches and Oral Film Revenue Market Share (2019-2024)
Table 29. World CDMO for Transdermal Patches and Oral Film Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & (USD Million)
Table 31. World CDMO for Transdermal Patches and Oral Film Market Size by Type (2025-2030) & (USD Million)
Table 32. World CDMO for Transdermal Patches and Oral Film Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & (USD Million)
Table 34. World CDMO for Transdermal Patches and Oral Film Market Size by Application (2025-2030) & (USD Million)
Table 35. AdhexPharma Basic Information, Area Served and Competitors
Table 36. AdhexPharma Major Business
Table 37. AdhexPharma CDMO for Transdermal Patches and Oral Film Product and Services
Table 38. AdhexPharma CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. AdhexPharma Recent Developments/Updates
Table 40. AdhexPharma Competitive Strengths & Weaknesses
Table 41. Nissha Basic Information, Area Served and Competitors
Table 42. Nissha Major Business
Table 43. Nissha CDMO for Transdermal Patches and Oral Film Product and Services
Table 44. Nissha CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Nissha Recent Developments/Updates
Table 46. Nissha Competitive Strengths & Weaknesses
Table 47. Tapemark Basic Information, Area Served and Competitors
Table 48. Tapemark Major Business
Table 49. Tapemark CDMO for Transdermal Patches and Oral Film Product and Services
Table 50. Tapemark CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Tapemark Recent Developments/Updates
Table 52. Tapemark Competitive Strengths & Weaknesses
Table 53. tesa Basic Information, Area Served and Competitors
Table 54. tesa Major Business
Table 55. tesa CDMO for Transdermal Patches and Oral Film Product and Services
Table 56. tesa CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. tesa Recent Developments/Updates
Table 58. tesa Competitive Strengths & Weaknesses
Table 59. LTS Lohmann Basic Information, Area Served and Competitors
Table 60. LTS Lohmann Major Business
Table 61. LTS Lohmann CDMO for Transdermal Patches and Oral Film Product and Services
Table 62. LTS Lohmann CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. LTS Lohmann Recent Developments/Updates
Table 64. LTS Lohmann Competitive Strengths & Weaknesses
Table 65. IntelGenx Basic Information, Area Served and Competitors
Table 66. IntelGenx Major Business
Table 67. IntelGenx CDMO for Transdermal Patches and Oral Film Product and Services
Table 68. IntelGenx CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. IntelGenx Recent Developments/Updates
Table 70. IntelGenx Competitive Strengths & Weaknesses
Table 71. MedPharm Basic Information, Area Served and Competitors
Table 72. MedPharm Major Business
Table 73. MedPharm CDMO for Transdermal Patches and Oral Film Product and Services
Table 74. MedPharm CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. MedPharm Recent Developments/Updates
Table 76. MedPharm Competitive Strengths & Weaknesses
Table 77. Adhesives Research Basic Information, Area Served and Competitors
Table 78. Adhesives Research Major Business
Table 79. Adhesives Research CDMO for Transdermal Patches and Oral Film Product and Services
Table 80. Adhesives Research CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Adhesives Research Recent Developments/Updates
Table 82. Adhesives Research Competitive Strengths & Weaknesses
Table 83. Shilpa Medicare Limited Basic Information, Area Served and Competitors
Table 84. Shilpa Medicare Limited Major Business
Table 85. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product and Services
Table 86. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Shilpa Medicare Limited Recent Developments/Updates
Table 88. Shilpa Medicare Limited Competitive Strengths & Weaknesses
Table 89. ROFARMA Basic Information, Area Served and Competitors
Table 90. ROFARMA Major Business
Table 91. ROFARMA CDMO for Transdermal Patches and Oral Film Product and Services
Table 92. ROFARMA CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. ROFARMA Recent Developments/Updates
Table 94. ROFARMA Competitive Strengths & Weaknesses
Table 95. Kindeva Drug Delivery Basic Information, Area Served and Competitors
Table 96. Kindeva Drug Delivery Major Business
Table 97. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product and Services
Table 98. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Kindeva Drug Delivery Recent Developments/Updates
Table 100. Kindeva Drug Delivery Competitive Strengths & Weaknesses
Table 101. ProSolus Basic Information, Area Served and Competitors
Table 102. ProSolus Major Business
Table 103. ProSolus CDMO for Transdermal Patches and Oral Film Product and Services
Table 104. ProSolus CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. ProSolus Recent Developments/Updates
Table 106. ProSolus Competitive Strengths & Weaknesses
Table 107. Altergon Basic Information, Area Served and Competitors
Table 108. Altergon Major Business
Table 109. Altergon CDMO for Transdermal Patches and Oral Film Product and Services
Table 110. Altergon CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Altergon Recent Developments/Updates
Table 112. Youwei Biotech Basic Information, Area Served and Competitors
Table 113. Youwei Biotech Major Business
Table 114. Youwei Biotech CDMO for Transdermal Patches and Oral Film Product and Services
Table 115. Youwei Biotech CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 116. Global Key Players of CDMO for Transdermal Patches and Oral Film Upstream (Raw Materials)
Table 117. CDMO for Transdermal Patches and Oral Film Typical Customers
LIST OF FIGURE
Figure 1. CDMO for Transdermal Patches and Oral Film Picture
Figure 2. World CDMO for Transdermal Patches and Oral Film Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World CDMO for Transdermal Patches and Oral Film Total Market Size (2019-2030) & (USD Million)
Figure 4. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 13. CDMO for Transdermal Patches and Oral Film Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 16. World CDMO for Transdermal Patches and Oral Film Consumption Value Market Share by Region (2019-2030)
Figure 17. United States CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 18. China CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 23. India CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of CDMO for Transdermal Patches and Oral Film by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for CDMO for Transdermal Patches and Oral Film Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for CDMO for Transdermal Patches and Oral Film Markets in 2023
Figure 27. United States VS China: CDMO for Transdermal Patches and Oral Film Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: CDMO for Transdermal Patches and Oral Film Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World CDMO for Transdermal Patches and Oral Film Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type in 2023
Figure 31. Transdermal Patches
Figure 32. Oral Film
Figure 33. World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2030)
Figure 34. World CDMO for Transdermal Patches and Oral Film Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application in 2023
Figure 36. Pharmaceutical Company
Figure 37. Biotechnology Company
Figure 38. Generic Company
Figure 39. CDMO for Transdermal Patches and Oral Film Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Table 1. World CDMO for Transdermal Patches and Oral Film Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World CDMO for Transdermal Patches and Oral Film Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World CDMO for Transdermal Patches and Oral Film Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World CDMO for Transdermal Patches and Oral Film Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World CDMO for Transdermal Patches and Oral Film Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World CDMO for Transdermal Patches and Oral Film Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World CDMO for Transdermal Patches and Oral Film Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key CDMO for Transdermal Patches and Oral Film Players in 2023
Table 12. World CDMO for Transdermal Patches and Oral Film Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global CDMO for Transdermal Patches and Oral Film Company Evaluation Quadrant
Table 14. Head Office of Key CDMO for Transdermal Patches and Oral Film Player
Table 15. CDMO for Transdermal Patches and Oral Film Market: Company Product Type Footprint
Table 16. CDMO for Transdermal Patches and Oral Film Market: Company Product Application Footprint
Table 17. CDMO for Transdermal Patches and Oral Film Mergers & Acquisitions Activity
Table 18. United States VS China CDMO for Transdermal Patches and Oral Film Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China CDMO for Transdermal Patches and Oral Film Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
Table 21. United States Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies CDMO for Transdermal Patches and Oral Film Revenue Market Share (2019-2024)
Table 23. China Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (Province, Country)
Table 24. China Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies CDMO for Transdermal Patches and Oral Film Revenue Market Share (2019-2024)
Table 26. Rest of World Based CDMO for Transdermal Patches and Oral Film Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies CDMO for Transdermal Patches and Oral Film Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies CDMO for Transdermal Patches and Oral Film Revenue Market Share (2019-2024)
Table 29. World CDMO for Transdermal Patches and Oral Film Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World CDMO for Transdermal Patches and Oral Film Market Size by Type (2019-2024) & (USD Million)
Table 31. World CDMO for Transdermal Patches and Oral Film Market Size by Type (2025-2030) & (USD Million)
Table 32. World CDMO for Transdermal Patches and Oral Film Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World CDMO for Transdermal Patches and Oral Film Market Size by Application (2019-2024) & (USD Million)
Table 34. World CDMO for Transdermal Patches and Oral Film Market Size by Application (2025-2030) & (USD Million)
Table 35. AdhexPharma Basic Information, Area Served and Competitors
Table 36. AdhexPharma Major Business
Table 37. AdhexPharma CDMO for Transdermal Patches and Oral Film Product and Services
Table 38. AdhexPharma CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. AdhexPharma Recent Developments/Updates
Table 40. AdhexPharma Competitive Strengths & Weaknesses
Table 41. Nissha Basic Information, Area Served and Competitors
Table 42. Nissha Major Business
Table 43. Nissha CDMO for Transdermal Patches and Oral Film Product and Services
Table 44. Nissha CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Nissha Recent Developments/Updates
Table 46. Nissha Competitive Strengths & Weaknesses
Table 47. Tapemark Basic Information, Area Served and Competitors
Table 48. Tapemark Major Business
Table 49. Tapemark CDMO for Transdermal Patches and Oral Film Product and Services
Table 50. Tapemark CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. Tapemark Recent Developments/Updates
Table 52. Tapemark Competitive Strengths & Weaknesses
Table 53. tesa Basic Information, Area Served and Competitors
Table 54. tesa Major Business
Table 55. tesa CDMO for Transdermal Patches and Oral Film Product and Services
Table 56. tesa CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. tesa Recent Developments/Updates
Table 58. tesa Competitive Strengths & Weaknesses
Table 59. LTS Lohmann Basic Information, Area Served and Competitors
Table 60. LTS Lohmann Major Business
Table 61. LTS Lohmann CDMO for Transdermal Patches and Oral Film Product and Services
Table 62. LTS Lohmann CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. LTS Lohmann Recent Developments/Updates
Table 64. LTS Lohmann Competitive Strengths & Weaknesses
Table 65. IntelGenx Basic Information, Area Served and Competitors
Table 66. IntelGenx Major Business
Table 67. IntelGenx CDMO for Transdermal Patches and Oral Film Product and Services
Table 68. IntelGenx CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. IntelGenx Recent Developments/Updates
Table 70. IntelGenx Competitive Strengths & Weaknesses
Table 71. MedPharm Basic Information, Area Served and Competitors
Table 72. MedPharm Major Business
Table 73. MedPharm CDMO for Transdermal Patches and Oral Film Product and Services
Table 74. MedPharm CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. MedPharm Recent Developments/Updates
Table 76. MedPharm Competitive Strengths & Weaknesses
Table 77. Adhesives Research Basic Information, Area Served and Competitors
Table 78. Adhesives Research Major Business
Table 79. Adhesives Research CDMO for Transdermal Patches and Oral Film Product and Services
Table 80. Adhesives Research CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Adhesives Research Recent Developments/Updates
Table 82. Adhesives Research Competitive Strengths & Weaknesses
Table 83. Shilpa Medicare Limited Basic Information, Area Served and Competitors
Table 84. Shilpa Medicare Limited Major Business
Table 85. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Product and Services
Table 86. Shilpa Medicare Limited CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Shilpa Medicare Limited Recent Developments/Updates
Table 88. Shilpa Medicare Limited Competitive Strengths & Weaknesses
Table 89. ROFARMA Basic Information, Area Served and Competitors
Table 90. ROFARMA Major Business
Table 91. ROFARMA CDMO for Transdermal Patches and Oral Film Product and Services
Table 92. ROFARMA CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. ROFARMA Recent Developments/Updates
Table 94. ROFARMA Competitive Strengths & Weaknesses
Table 95. Kindeva Drug Delivery Basic Information, Area Served and Competitors
Table 96. Kindeva Drug Delivery Major Business
Table 97. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Product and Services
Table 98. Kindeva Drug Delivery CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Kindeva Drug Delivery Recent Developments/Updates
Table 100. Kindeva Drug Delivery Competitive Strengths & Weaknesses
Table 101. ProSolus Basic Information, Area Served and Competitors
Table 102. ProSolus Major Business
Table 103. ProSolus CDMO for Transdermal Patches and Oral Film Product and Services
Table 104. ProSolus CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. ProSolus Recent Developments/Updates
Table 106. ProSolus Competitive Strengths & Weaknesses
Table 107. Altergon Basic Information, Area Served and Competitors
Table 108. Altergon Major Business
Table 109. Altergon CDMO for Transdermal Patches and Oral Film Product and Services
Table 110. Altergon CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Altergon Recent Developments/Updates
Table 112. Youwei Biotech Basic Information, Area Served and Competitors
Table 113. Youwei Biotech Major Business
Table 114. Youwei Biotech CDMO for Transdermal Patches and Oral Film Product and Services
Table 115. Youwei Biotech CDMO for Transdermal Patches and Oral Film Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 116. Global Key Players of CDMO for Transdermal Patches and Oral Film Upstream (Raw Materials)
Table 117. CDMO for Transdermal Patches and Oral Film Typical Customers
LIST OF FIGURE
Figure 1. CDMO for Transdermal Patches and Oral Film Picture
Figure 2. World CDMO for Transdermal Patches and Oral Film Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World CDMO for Transdermal Patches and Oral Film Total Market Size (2019-2030) & (USD Million)
Figure 4. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World CDMO for Transdermal Patches and Oral Film Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company CDMO for Transdermal Patches and Oral Film Revenue (2019-2030) & (USD Million)
Figure 13. CDMO for Transdermal Patches and Oral Film Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 16. World CDMO for Transdermal Patches and Oral Film Consumption Value Market Share by Region (2019-2030)
Figure 17. United States CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 18. China CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 23. India CDMO for Transdermal Patches and Oral Film Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of CDMO for Transdermal Patches and Oral Film by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for CDMO for Transdermal Patches and Oral Film Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for CDMO for Transdermal Patches and Oral Film Markets in 2023
Figure 27. United States VS China: CDMO for Transdermal Patches and Oral Film Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: CDMO for Transdermal Patches and Oral Film Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World CDMO for Transdermal Patches and Oral Film Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type in 2023
Figure 31. Transdermal Patches
Figure 32. Oral Film
Figure 33. World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Type (2019-2030)
Figure 34. World CDMO for Transdermal Patches and Oral Film Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 35. World CDMO for Transdermal Patches and Oral Film Market Size Market Share by Application in 2023
Figure 36. Pharmaceutical Company
Figure 37. Biotechnology Company
Figure 38. Generic Company
Figure 39. CDMO for Transdermal Patches and Oral Film Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
